NASDAQ: PRENW - Prenetics Holding Company Limited

Rentabilität für sechs Monate: 0%
Dividendenrendite: 0.00%

Aktionsplan Prenetics Holding Company Limited

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Prenetics Holding Company Limited

Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes Insighta, a multi-cancer early detection technology. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests.

weitere details
Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. It operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2022-05-18
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.prenetics.com
Цена ао 0.0104
Preisänderung pro Tag: 0% (0.0108)
Preisänderung pro Woche: +11.34% (0.0097)
Preisänderung pro Monat: -22.3% (0.0139)
Preisänderung über 3 Monate: +9.09% (0.0099)
Preisänderung über sechs Monate: 0% (0.0108)
Preisänderung pro Jahr: +47.95% (0.0073)
Preisänderung seit Jahresbeginn: +8% (0.01)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 135.49 10
Rentabilität Ebitda, % 158.67 10
Rentabilität EPS, % 104.33 10
Gesamt: 10
Weitere Details

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO 1979 (46 Jahre)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer 1974 (51 Jahr)
Mr. Hoi Chun Lo Chief Financial Officer 1985 (40 Jahre)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations
Dr. Yung Ho Wong DPHIL Chief Technology Officer 1982 (43 Jahr)
Dr. Senthil Sundaram M.D. Chief Clinical Officer 1974 (51 Jahr)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA 1984 (41 Jahr)
Mr. Walt Ling Chief Executive Officer of ACT Genomics

Adresse: Hong Kong, Quarry Bay, Unit 703-706 K11 Atelier King’s Road - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.prenetics.com